sermorelin peptide and tirzepatide together + Tirzepatide: Safety & Efficacy Peptide Therapy | Sermorelin, BPC-157,
Description
Excess body weight can increase blood pressure by raising inflammation, affecting insulin resistance, increasing fluid retention, and placing more strain on the cardiovascular system
Patients with a history of
doi: 10.1111/resp.13838, 3
In contrast, metformin primarily addresses insulin resistance, while semaglutide focuses solely on activating GLP-1 receptors
Reductions in fat-free muscle volume were small and within expected ranges based on UK Biobank reference data
Dose reduction or temporary treatment interruption may be necessary in some cases
